Monitoring fatigue and attention in sleep-deprived medical residents
Official title: MONITORING OF ATTENTION ACCORDING TO FATIGUE IN THE HEALTHY SUBJECT
Run by Assistance Publique - Hôpitaux de Paris · NCT05531734 · Data updated 2026-11-12
This study is testing a new device that helps track fatigue and alertness in medical residents working night shifts to see if it can spot changes in their brain activity when they’re sleep-deprived.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Garches) |
| Status | Recruiting |
| Started | March 22, 2023 |
| Main results expected | September 2025 |
| Study ends | September 2025 |
| Registry record updated | April 27, 2025 |
| Trial ID | NCT05531734 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy medical residents aged 24 to 34 who work night shifts in emergency or intensive care settings.
✕Probably not a fit
Patients who are not medical residents or those with a history of epilepsy or significant medication affecting EEG data may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to develop a user-friendly measurement tool, the NaoX device, to monitor fatigue and alertness in medical residents who experience sleep deprivation during night shifts. The primary objective is to demonstrate that the NaoX tool can effectively detect changes in brain activity, specifically a decrease in Coefficient Alpha Attenuation (CAA), before and after sleep deprivation. Secondary objectives include establishing correlations between the NaoX measurements and performance on vigilance tests, as well as self-reported fatigue levels. The study involves multiple recordings and assessments conducted over a series of shifts to gather comprehensive data.
Why it matters
Potential benefit: If successful, this study could provide a reliable tool for monitoring fatigue in medical professionals, potentially improving patient safety and resident well-being.
How similar studies have gone: While the approach of using EEG data to monitor fatigue is established, the specific application of the NaoX tool in this context is novel and has not been extensively tested in similar populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy volunteers. * Male, female. * Medical residents. * Aged between 24 and 34 years. * Doing emergency, intensive care or "inside" shifts. * Working in a health institution. * No history of epilepsy. * No background treatment that could have an impact on the EEG (electroencephalogram) data (type: benzodiazepines, anti-epileptics). * No significant change in background treatment during the study, if any. * Affiliation to the social security system. * Informed volunteer who has signed a consent form. Exclusion Criteria: \-
Where it's running
-
Pediatric Intensive Care Unit, Raymond Poincaré Hospital, APHP
Garches, France Recruiting
Study contacts
- Principal investigator: Jean BERGOUNIOUX, MD, PhD — Pediatric Intensive Care Unit, Raymond Poincaré Hospital, APHP
- Study coordinator: Jean BERGOUNIOUX, MD, PhD
- Email: jean.bergounioux@gmail.com
- Phone: + 33 (0)1 47 10 79 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Sleep and circadian care for ICU patients
This study tests a multicomponent sleep and circadian rhythm program in adult ICU patients to see if it helps keep daily rhythms and sleep better.
-
HBS-104 single doses in acutely sleep-deprived healthy adults
This study tests whether a single dose of HBS-104 is safe and how it behaves in the body when given to healthy adults who are acutely sleep-deprived.
-
Micro-choice-based approach to fatigue management
A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.
-
HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults
This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.
-
See if Nuvastatic helps with cancer-related fatigue in colon cancer patients on first-line chemotherapy
This trial tests whether Nuvastatic can lessen fatigue in adults with colon cancer who are receiving their first round of chemotherapy, compared to placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.